Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s stock price shot up 1.6% during mid-day trading on Thursday . The company traded as high as $4.44 and last traded at $4.42. 649,754 shares were traded during trading, an increase of 362% from the average session volume of 140,656 shares. The stock had previously closed at $4.35.
Ono Pharmaceutical Stock Performance
The business’s 50 day simple moving average is $4.62 and its 200-day simple moving average is $4.73.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
See Also
- Five stocks we like better than Ono Pharmaceutical
- Overbought Stocks Explained: Should You Trade Them?
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Top Biotech Stocks: Exploring Innovation Opportunities
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- What is Put Option Volume?
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
